🇧🇷 Dopram in Brazil

Dopram (DOXAPRAM) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Dopram in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Brazil

Frequently asked questions

Is Dopram approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Dopram in Brazil?

Hikma is the originator. The local marketing authorisation holder may differ — check the official source linked above.